Role of NF-kappaB2-p100 in regulatory T cell homeostasis and activation.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
25 09 2019
25 09 2019
Historique:
received:
04
06
2019
accepted:
10
09
2019
entrez:
27
9
2019
pubmed:
27
9
2019
medline:
3
11
2020
Statut:
epublish
Résumé
The immunological roles of the nuclear factor-kappaB (NF-κB) pathway are mediated via the canonical components in immune responses and via non-canonical components in immune organogenesis and homeostasis, although the two components are capable of crosstalk. Regulatory CD4 T cells (Tregs) are homeostatically functional and represent an interesting potential meeting point of these two NF-κB components. We show that mice deficient in the non-canonical NF-κB component gene Nfkb2 (p100) had normal thymic development and suppressive function of Tregs. However, they had enhanced frequencies of peripheral 'effector-phenotype' Tregs (eTregs). In bi-parental chimeras of wild-type (WT) and Nfkb2-/- mice, the Nfkb2-/- genotype was over-represented in Tregs, with a further increase in the relative prominence of eTregs. Consistent with distinct properties of eTregs, the Nfkb2-/- genotype was more prominent in Tregs in extra-lymphoid tissues such as liver in the bi-parental chimeras. The Nfkb2-/- Tregs also displayed greater survival, activation and proliferation in vivo. These Nfkb2-/- Tregs showed higher nuclear NF-κB activity mainly comprising of RelB-containing dimers, in contrast to the prominence of cRel- and RelA-containing dimers in WT Tregs. Since p100 is an inhibitor of RelB activation as well as a participant as cleaved p52 in RelB nuclear activity, we tested bi-parental chimeras of WT and Relb-/- mice, and found normal frequencies of Relb-/- Tregs and eTregs in these chimeric mice. Our findings confirm and extend recent data, and indicate that p100 normally restrains RelB-mediated Treg activation, and in the absence of p100, p50-RelB dimers can contribute to Treg activation.
Identifiants
pubmed: 31554891
doi: 10.1038/s41598-019-50454-z
pii: 10.1038/s41598-019-50454-z
pmc: PMC6761191
doi:
Substances chimiques
NF-kappa B p52 Subunit
0
Nfkb2 protein, mouse
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
13867Références
J Biol Chem. 2003 Jun 27;278(26):23278-84
pubmed: 12709443
Clin Exp Immunol. 2016 Sep;185(3):281-91
pubmed: 27124481
Immunity. 2009 May;30(5):626-35
pubmed: 19464985
Immunology. 2006 Jun;118(2):240-9
pubmed: 16771859
Annu Rev Immunol. 2009;27:693-733
pubmed: 19302050
Immunity. 2008 Mar;28(3):402-13
pubmed: 18328743
J Exp Med. 2012 Sep 24;209(10):1723-42, S1
pubmed: 22966001
J Immunol. 2007 Jun 15;178(12):7767-78
pubmed: 17548614
Cell Rep. 2014 Dec 24;9(6):2098-111
pubmed: 25497099
Nat Rev Immunol. 2014 Mar;14(3):154-65
pubmed: 24481337
Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
J Immunol. 2013 Jan 15;190(2):549-55
pubmed: 23248260
J Exp Med. 2009 Dec 21;206(13):3001-14
pubmed: 19995950
J Exp Med. 2007 Jun 11;204(6):1257-65
pubmed: 17502665
Science. 2003 Feb 14;299(5609):1057-61
pubmed: 12522256
J Exp Med. 2014 Jan 13;211(1):121-36
pubmed: 24378538
Oncogene. 2016 Jun 16;35(24):3083-91
pubmed: 26500059
Immunity. 2017 Sep 19;47(3):450-465.e5
pubmed: 28889947
Nucleic Acids Res. 2018 Jul 2;46(W1):W537-W544
pubmed: 29790989
Nucleic Acids Res. 2007 Jul;35(Web Server issue):W193-200
pubmed: 17478515
Cell. 2017 Sep 7;170(6):1096-1108.e13
pubmed: 28886380
J Immunol. 2018 Feb 15;200(4):1325-1334
pubmed: 29298831
PLoS One. 2012;7(3):e34547
pubmed: 22479644
J Exp Med. 2011 Jun 6;208(6):1279-89
pubmed: 21606508
Genome Biol. 2014;15(12):550
pubmed: 25516281
Blood. 2007 Jan 1;109(1):194-202
pubmed: 16968902
J Immunol. 2013 May 15;190(10):5057-64
pubmed: 23576681
Cell Rep. 2017 Sep 19;20(12):2906-2920
pubmed: 28889989
J Immunol. 2007 Jan 1;178(1):301-11
pubmed: 17182567
J Exp Med. 2007 Jun 11;204(6):1335-47
pubmed: 17548521
Cell Death Differ. 2018 Jan;25(1):65-80
pubmed: 29149100
J Exp Med. 1998 Jan 19;187(2):185-96
pubmed: 9432976
Nat Immunol. 2014 Jan;15(1):15-25
pubmed: 24352326
J Immunol. 2010 Sep 15;185(6):3295-304
pubmed: 20720211
Nat Protoc. 2007;2(7):1789-94
pubmed: 17641646
Immunity. 2008 Jan;28(1):100-11
pubmed: 18199417
J Exp Med. 2000 Jul 17;192(2):295-302
pubmed: 10899916
Elife. 2015 Apr 23;4:
pubmed: 25905673
J Exp Med. 2003 Sep 1;198(5):737-46
pubmed: 12939344
Immunity. 2003 Sep;19(3):377-89
pubmed: 14499113
Oncogene. 2001 Nov 22;20(53):7722-33
pubmed: 11753650
FASEB J. 2015 Feb;29(2):443-54
pubmed: 25376833
Proc Natl Acad Sci U S A. 2014 Nov 11;111(45):15946-51
pubmed: 25349408
Nat Immunol. 2014 Nov;15(11):1070-8
pubmed: 25263123
Front Immunol. 2019 May 07;10:997
pubmed: 31134075
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
J Clin Invest. 2013 Feb;123(2):580-93
pubmed: 23281398
Curr Mol Med. 2011 Nov;11(8):633-49
pubmed: 21902653
Immunity. 2014 Nov 20;41(5):722-36
pubmed: 25464853
Proc Natl Acad Sci U S A. 2009 Jun 16;106(24):9619-24
pubmed: 19487661
Cancer Immunol Res. 2013 Nov;1(5):320-31
pubmed: 24416730
Int Immunol. 2008 Mar;20(3):307-15
pubmed: 18184698
Nucleic Acids Res. 2018 Jan 4;46(D1):D754-D761
pubmed: 29155950
J Immunol. 1996 Nov 1;157(9):3974-9
pubmed: 8892630
Nat Immunol. 2002 Feb;3(2):135-42
pubmed: 11812990
J Clin Invest. 2006 Nov;116(11):2964-71
pubmed: 17039258
J Immunol. 2005 Feb 15;174(4):1783-6
pubmed: 15699103
Int J Clin Exp Pathol. 2013;6(2):116-23
pubmed: 23329997
Nat Methods. 2015 Apr;12(4):357-60
pubmed: 25751142
Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3503-8
pubmed: 18292232
J Immunol. 2008 Jan 15;180(2):774-82
pubmed: 18178815
Eur J Immunol. 2019 Mar;49(3):398-412
pubmed: 30620397
Nucleic Acids Res. 2018 Jan 4;46(D1):D649-D655
pubmed: 29145629
J Immunol. 1995 Aug 1;155(3):1151-64
pubmed: 7636184
J Immunol. 2007 Feb 1;178(3):1433-42
pubmed: 17237391
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
Mediators Inflamm. 2016;2016:7132158
pubmed: 27239104
PLoS One. 2013 Sep 20;8(9):e76216
pubmed: 24073289
J Autoimmun. 2016 Jun;70:52-62
pubmed: 27068879
Front Immunol. 2018 Dec 18;9:2969
pubmed: 30619326
Nat Immunol. 2006 Jul;7(7):763-72
pubmed: 16732290
Nat Rev Immunol. 2017 Sep;17(9):545-558
pubmed: 28580957
J Immunol. 2011 Sep 15;187(6):3186-97
pubmed: 21849683
Nat Immunol. 2011 Apr;12(4):304-11
pubmed: 21378976
Nat Commun. 2015 Sep 14;6:8266
pubmed: 26365427
Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):13031-6
pubmed: 12242333
Dev Biol. 2010 Jun 15;342(2):146-56
pubmed: 20347762
J Immunol. 2002 Sep 1;169(5):2461-5
pubmed: 12193715
Blood. 2012 May 31;119(22):5155-63
pubmed: 22403258
J Immunol. 2018 Apr 1;200(7):2362-2371
pubmed: 29459403
Oncogene. 2017 Mar;36(10):1417-1429
pubmed: 27641334